Susquehanna Starts Genesis Healthcare (GEN) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts GEN Hot Sheet
Price: $23.25 +2.20%
Rating Summary:
8 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
8 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Susquehanna initiated coverage on Genesis Healthcare (NYSE: GEN) with a Neutral rating and a price target of $7.50.
For an analyst ratings summary and ratings history on Genesis Healthcare click here. For more ratings news on Genesis Healthcare click here.
Shares of Genesis Healthcare closed at $6.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gen Digital adds Blackhawk Network CEO Talbott Roche to its board
- BNP Paribas Exane Starts BellRing Brands (BRBR) at Outperform
- JPMorgan Resumes Trane Technologies (TT) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
